Alsatinib 20 mg Tablet

Get a Price/Quote

MOQ : 150 Boxes

Alsatinib 20 mg Tablet Specification

Origin of Medicine
INDIA

Physical Form
Tablets

Recommended For
DOCTOR

Quantity
150 Boxes

Brand Name
Alsatinib

Colour
Light Yellow

Tablet Strength
20 mg

Packing Type
Box

Medicine Type
Anti-cancer

Shape
Round

Route
Oral

Storage Temperature
Below 30°C

Alsatinib 20 mg Tablet Trade Information

Minimum Order Quantity
150 Boxes

Delivery Time
1 Week

About Alsatinib 20 mg Tablet

Alsatinib 20 mg Tablet is an innovative anti-cancer treatment primarily used to manage chronic myeloid leukemia (CML) and certain types of acute lymphoblastic leukemia (ALL). The active ingredient, dasatinib, functions by inhibiting specific proteins that promote the growth of cancer cells, effectively slowing down or halting the progression of the disease. Patients using Alsatinib should be aware of potential side effects such as fluid retention, low blood cell counts, and cardiovascular issues, making regular monitoring essential. This medication is typically prescribed when other treatments have proven ineffective or for patients with specific genetic markers. It is crucial to follow your healthcare provider's instructions carefully to ensure optimal results and minimize risks. As with any cancer treatment, discussing your full medical history and any other medications you are taking with your doctor is important to avoid harmful interactions. Alsatinib represents a significant advancement in targeted cancer therapy, providing hope for individuals fighting these challenging conditions. Always consult your healthcare professional for personalized advice and guidance when considering Alsatinib as part of your treatment plan.

Precision Engineered Anti-Cancer Therapy

Alsatinib 20 mg Tablet offers targeted cancer treatment with a defined strength of 20 mg per tablet. Its oral route and user-friendly packaging make it suitable for medical professionals to distribute and oversee its use. The light yellow, round tablets are designed for easy identification and handling within clinical settings.

Reliable Origin and Quality Assurance

Manufactured in India, Alsatinib 20 mg Tablet meets stringent quality standards and is accessible to a range of healthcare providers. Its box packaging enhances both storage and transport, ensuring the integrity and potency of the medication from manufacturer to end-user.

FAQ's of Alsatinib 20 mg Tablet:

Q: How should Alsatinib 20 mg Tablets be stored for maximum effectiveness?

A: Alsatinib 20 mg Tablets must be stored at temperatures below 30C to maintain their stability and efficacy. Avoid exposure to moisture and direct sunlight by keeping the tablets in their original box packaging.

Q: What is the recommended process for administering Alsatinib 20 mg Tablets?

A: Alsatinib is to be taken orally as prescribed by a healthcare professional. The dosage and treatment duration depend on the specific condition being treated and should be strictly followed as advised by the doctor.

Q: When is Alsatinib 20 mg Tablet typically prescribed?

A: This medication is generally prescribed in cases where targeted anti-cancer therapy is required. Only healthcare professionals should determine its suitability based on the patient's clinical evaluation.

Q: Where can Alsatinib 20 mg Tablets be sourced and who are they recommended for?

A: Alsatinib 20 mg Tablets originate from India and are intended for procurement by doctors, distributors, exporters, suppliers, traders, and wholesalers specializing in oncology medications.

Q: What are the benefits of using Alsatinib 20 mg Tablets?

A: The main benefit of Alsatinib Tablets is their advanced formulation, which provides targeted action against cancer cells. Their oral route aids patient compliance, and the product's recognized quality ensures optimal therapeutic results.

Q: Who should oversee the usage of Alsatinib 20 mg Tablets?

A: Administration and monitoring of Alsatinib should always be performed by qualified medical professionals to guarantee patient safety and effective treatment outcomes.

Tell us about your requirement